Gossamer Bio, Inc. - Common Stock (GOSS)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / Common Stock
Shares outstanding
227M
Number of holders
114
Total 13F shares, excl. options
104M
Shares change
+18.1M
Total reported value, excl. options
$225M
Value change
-$165M
Put/Call ratio
0.71
Number of buys
65
Number of sells
-87
Price
$2.17

Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2022

188 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q4 2022.
Gossamer Bio, Inc. - Common Stock (GOSS) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 104M shares of 227M outstanding shares and own 45.64% of the company stock.
Largest 10 shareholders include STATE STREET CORP (27.8M shares), VANGUARD GROUP INC (7.96M shares), BlackRock Inc. (5.41M shares), HHLR ADVISORS, LTD. (4.97M shares), MILLENNIUM MANAGEMENT LLC (4.63M shares), Weiss Asset Management LP (3.64M shares), NEA Management Company, LLC (3.47M shares), Boxer Capital, LLC (3.34M shares), Artal Group S.A. (3.25M shares), and MORGAN STANLEY (3.16M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.